Need help?

Diagnostic Substances Manufacturing Businesses for Sale and Investment

Showing 1 - 5 of 5 Diagnostic Substances Manufacturing Businesses for Sale and Investment. Buy or Invest in a Diagnostic Substance Manufacturing Business. Listed by Direct Business Owners & Business Brokers.
Filters
  • Diagnostic Substances Manufacturing

 

Profitable Diagnostic Substances Manufacturing Company Investment Opportunity in Bhopal, India

FDA, WHO, and ISO compliant company manufacturing high-quality in vitro diagnostic products, clinical chemistry reagents.
The company specializes in manufacturing high-quality in vitro diagnostic products, clinical chemistry reagents and rapid diagnostic tests. - The company serves over 100 clients, including hospitals, diagnostic laboratories, and POCT providers. - Our revenue model includes direct sales to healthcare institutions and laboratories. - We engage in B2B sales of uncut sheets of urine strips to other manufacturers. - Company forms OEM partnerships and offers custom packaging solutions for clients. - We also conduct sales through distributors and marketing partners. - Our promoters bring over three decades of expertise in the healthcare industry, specializing in the development and production of in vitro diagnostic products. - We have a strong background in quality assurance, adhering to ISO 13485:2016 and GMP standards. - The company is ISO 13485:2016 and GMP certified. - We hold a startup certificate and are selected under the BIRAC scheme for innovative product development. - The company collaborates with academic and research institutions, including a notable partnership with IIT Kanpur for developing a TB RT-PCR kit under the BIRAC scheme. - Our product range includes a comprehensive array of clinical diagnostic reagents and test kits. - We offer custom packaging options tailored to client requirements. - Company is committed to continuous improvement and total quality assurance. - Our highlights showcase our dedication to delivering superior-quality diagnostic products, fostering strong industry relationships, and maintaining a robust quality management system. - We boast a state-of-the-art manufacturing plant in Bhopal, fully compliant with Indian FDA, WHO, and ISO 13485 standards. - Our manufacturing capacity includes: - Rapid Card: 5 million tests/month. - Biochemistry: 10,000 liters of reagents/month. - Hematology: 25,000 liters of reagents/month. - Urine Strip: 300,000 strips/day. - The company has a highly motivated and experienced team excelling in manufacturing, quality control, regulatory compliance, and supply chain management. - We have a provision for a 3-row assembly room, ensuring efficient and reliable production to meet extensive testing capabilities. - Our facility is a testament to our commitment to high-quality manufacturing and our readiness to seize future business opportunities while maintaining the highest standards of compliance and efficiency.
FDA, WHO, and ISO compliant company manufacturing high-quality in vitro diagnostic products, clinical chemistry reagents.
8.7   Bhopal
Run Rate Sales
USD 140 thousand
EBITDA Margin
40 %
Partial Stake Sale
USD 375 K for 50%
Contact Business

Newly Established Diagnostic Substances Manufacturing Company Investment Opportunity in Calgary, Canada

Radiology imaging drug manufacturing company based in Alberta, seeking investment for establishing manufacturing facility.
Company based in Calgary, Alberta focused on the manufacturing and sales of radiology imaging drugs, with a specific emphasis on barium contrast drugs used by both private and government healthcare facilities in the radiology industry, currently in the pre-revenue stage. - The company is in the process of developing iodine drugs and creating new endohedral fullerene drugs from captured CO2, targeting a market valued at $6.5 billion. - With plans to commence operations this year, the company emphasizes the strategic importance of critical minerals required for the creation of radiology drugs, and it possesses its own resources, enabling it to vertically integrate its radiology drug business. - Aspiring to become the first vertically-integrated North American supplier of medical imaging contrast agents, the company is focused on producing a line of generic and new innovative barium and iodine radiology imaging contrast media products. Additionally, involved in the development of a new carbon fullerene drug for magnetic resonance imaging (MRI). - These products will be supplied to healthcare and imaging facilities. The first contract was signed for USD 1.9M. - Business has 5 Health Canada drug licenses, partnership and exclusive rights to develop endohedral fullerene drugs for the radiology imaging market, and a carbon capture program for future carbon revenue generation.
6.8   Calgary
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 2.9 Mn for 26%
Contact Business

Diagnostic Substances Manufacturing Company for Sale in Kashipur, India

For-Sale: IV-fluid manufacturer, 5 years experience, 8 lakhs/day production capacity, and 35 partner distribution networks.
Leading IV fluid manufacturer with cutting-edge machinery for superior quality. - Impressive manufacturing capacity: - Maximum production: 10 lakhs bottles/day. - Average production: 8 lakhs/day. - 5 years of invaluable industry experience. - Trusted suppliers from Gujarat, Bombay, and Delhi (10 in total). - Extensive B2B distribution network with 35 partners covering the entire northern region. - Compliant with WHO-GMP standards, ensuring product excellence. - The company is breaking even at the moment.
5.9   Kashipur
Run Rate Sales
USD 1.7 million
EBITDA Margin
Nil
Business for Sale
USD 11.7 Mn
Contact Business
List your business on SMERGERS.
Get visibility from 110,000+ member network of Businesses, Investors, Acquirers, Lenders and Advisors from 900+ Industries and 170+ Countries
Create Business Profile

Diagnostic Substances Manufacturing Company for Sale in Kashipur, India

For-Sale: IV-fluid manufacturer, 5 years experience, 8 lakhs/day production capacity, and 35 partner distribution networks.
Leading IV fluid manufacturer with cutting-edge machinery for superior quality. - Impressive manufacturing capacity: - Maximum production: 10 lakhs bottles/day. - Average production: 8 lakhs/day. - 5 years of invaluable industry experience. - Trusted suppliers from Gujarat, Bombay, and Delhi (10 in total). - Extensive B2B distribution network with 35 partners covering the entire northern region. - Compliant with WHO-GMP standards, ensuring product excellence. - The company is breaking even at the moment.
5.9   Kashipur
Run Rate Sales
USD 1.7 million
EBITDA Margin
Nil
Business for Sale
USD 11.7 Mn
Contact Business

Profitable Diagnostic Substances Manufacturing Company Investment Opportunity in Acharnes, Greece

Established producer of diagnostic tests and reagents with patents seeks an investor.
Rapidly expanding manufacturer and supplier of medical diagnostic reagents and food industry detection kits. - We are an independent Greek-based primary manufacturer, supplying a worldwide network of distributors, agents, and NGOs. - The company needs a lot of highly skilled employees for handling sensitive raw materials and production machines.
7.8   Acharnes
Run Rate Sales
USD 405 thousand
EBITDA Margin
10 %
Partial Stake Sale
USD 113 K for 10%
Contact Business

Diagnostic Substances Manufacturing Company Investment Opportunity in Allahabad, India

Manufacturing & marketing of pharmaceuticals products covering 800+ drug stores seek investment for expansion.
For the past 6 years, we have been in this industry and last year we registered this company as a Pvt Ltd company. - We have agreements with pharma companies to manufacture their products. - We buy raw materials from these companies and manufacture the products based on the instructions provided by them. - We then distribute it to the local market. - Currently, we are dealing with 19 products and promoting the products via 1,500 doctors with 40 dealers and covering 800 chemist stores. - We are aiming to cover 15,000 doctors 7,000 chemists 300 distributors with a business stake of approx INR 5 Cr by the end of 3 years from now.
5.8   Allahabad
Run Rate Sales
USD 112 thousand
EBITDA Margin
35 %
Partial Stake Sale
USD 117 K for 30%
Contact Business
Frequently
Asked
Questions
  • How many diagnostic substances manufacturing businesses for sale and investment are listed on SMERGERS?
    There are 5 active and verified diagnostic substances manufacturing businesses for sale and investment listed on SMERGERS as of 15 May 2025.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more